Clinical Trial Update: Effect of BM-MSCs on Chronic AMR After Kidney Transplantation [Phase 1, Phase 2]

View source ↗

Summary

This document reports on a Phase 1/Phase 2 trial evaluating bone marrow-derived mesenchymal stem cells (BM-MSCs) for chronic antibody-mediated rejection after k…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antibody-mediated Rejection

Drugs mentioned

• Bone marrow-derived mesenchymal stem cells (BM-MSCs) (bone marrow-derived mesenchymal stem cells)

Snippet

Sponsor: First Affiliated Hospital, Sun Yat-Sen University | Conditions: Kidney Transplantation | Phase 1, Phase 2 | Status: UNKNOWN